BRPI0410074A - compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele - Google Patents

compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele

Info

Publication number
BRPI0410074A
BRPI0410074A BRPI0410074-3A BRPI0410074A BRPI0410074A BR PI0410074 A BRPI0410074 A BR PI0410074A BR PI0410074 A BRPI0410074 A BR PI0410074A BR PI0410074 A BRPI0410074 A BR PI0410074A
Authority
BR
Brazil
Prior art keywords
processes
compounds
optionally substituted
production
elastin
Prior art date
Application number
BRPI0410074-3A
Other languages
English (en)
Inventor
Hugo Ziegler
Marc Heidl
Dominik Imfeld
Original Assignee
Pentapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm Ag filed Critical Pentapharm Ag
Publication of BRPI0410074A publication Critical patent/BRPI0410074A/pt
Publication of BRPI0410074B1 publication Critical patent/BRPI0410074B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)

Abstract

"COMPOSTOS, PROCESSO PARA A PREPARAçãO E USO DOS MESMOS, COMPOSIçãO, E, PROCESSO PARA O INCREMENTO DA PRODUçãO DE COLáGENO E/OU ELASTINA NA PELE HUMANA E/OU PARA O RETARDAMENTO OU O TRATAMENTO DO ENVELHECIMENTO DA PELE". Compostos e sais cosmeticamente aceitáveis dos mesmos, que correspondem à fórmula geral (I) sendo que: R¬ 1¬ representa H, -C(O)-R¬ 6¬, -SO~ 2~-R¬ 6¬ ou -C(O)-XR¬ 6¬; R¬ 2¬ e R¬ 4¬ = independentemente um do outro, representam (CH~ 2~)~ n~,-NH~ 2~ ou (CH~ 2~)~ 3~NHC(NH)NH~ 2~; n = 1-4; R~ 3~ = C~ 1~-C~ 4~ -alquila linear ou ramificado opcionalmente substituído por hidroxila; R¬ 5¬ e R¬ 6¬ = independentemente um do outro, representam hidrogênio, (C~ 1~-C~ 24~)-alquila opcionalmente substituido, C~ 2-C~ 24~-alquenila opcionalmente substituído, fenila opcionalmente substituído, fenil-C~ 1~-C~ 4~-alquila opcionalmente substituído ou 9-fluorenilmetila; X = oxigênio (-O-) ou -NH-; ou XR 5¬ com X = O também representa os ésteres de <244>-tocoferol, tocotrienol ou retinol, com a condição de que R¬ 1¬ e R¬ 5¬ não representem hidrogênio e X não represente oxigênio ao mesmo tempo; a preparação dos compostos de fórmula geral (I); composição cosmeticamente ativa que compreende pelo menos um composto de fórmula (I).
BRPI0410074-3A 2003-05-08 2004-05-07 Compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele BRPI0410074B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH807/03 2003-05-08
CH8072003 2003-05-08
PCT/CH2004/000278 WO2004099237A1 (de) 2003-05-08 2004-05-07 Tripeptide und deren derivate für die kosmetische verwendung zur verbesserung der hautstruktur

Publications (2)

Publication Number Publication Date
BRPI0410074A true BRPI0410074A (pt) 2006-05-23
BRPI0410074B1 BRPI0410074B1 (pt) 2020-03-10

Family

ID=33426270

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410074-3A BRPI0410074B1 (pt) 2003-05-08 2004-05-07 Compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele

Country Status (12)

Country Link
US (2) US7863417B2 (pt)
EP (1) EP1625150B9 (pt)
JP (2) JP4769709B2 (pt)
KR (1) KR101116528B1 (pt)
AT (1) ATE350389T1 (pt)
BR (1) BRPI0410074B1 (pt)
CA (1) CA2525476C (pt)
DE (1) DE502004002556D1 (pt)
ES (1) ES2280962T3 (pt)
PL (1) PL1625150T3 (pt)
RU (1) RU2346949C2 (pt)
WO (1) WO2004099237A1 (pt)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1625150T3 (pl) * 2003-05-08 2007-05-31 Dsm Ip Assets Bv Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry
FR2870243B1 (fr) * 2004-05-11 2010-11-19 Centre Nat Rech Scient Conjugues tripeptidiques agonistes de la msh
FR2870244B1 (fr) 2004-05-11 2011-01-07 Centre Nat Rech Scient Conjugues dipeptidiques antagonistes de l'alpha-msh
AU2014271339B2 (en) * 2005-04-27 2016-11-03 The Procter & Gamble Company Personal care compositions
US20070020220A1 (en) * 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
WO2007093839A1 (en) * 2006-02-16 2007-08-23 Sederma New polypeptides kxk and their use
ES2283212B1 (es) * 2006-03-31 2008-08-16 Lipotec S.A. Peptidos sinteticos utiles en el tratamiento de la piel y su uso en composiciones cosmeticas o dermofarmaceuticas.
KR101332578B1 (ko) 2006-04-28 2013-11-25 디에스엠 아이피 어셋츠 비.브이. 기저막의 단백질 합성 자극용 화장료 조성물
US8586541B2 (en) * 2006-06-01 2013-11-19 Therapeutic Peptides, Inc. Polymeric biosurfactants
ES2322882B1 (es) * 2006-10-25 2010-04-22 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal.
EP1992332A1 (en) * 2007-05-08 2008-11-19 Tupperware Products S.A. Cosmetic anti ageing skin care compositions
CH696838A5 (it) * 2007-05-29 2007-12-31 Labo Cosprophar Ag Composizione cosmetica ad effetto lifting per sostenere tessuti cutanei rilassati.
KR101557814B1 (ko) * 2007-07-05 2015-10-06 닛산 가가쿠 고교 가부시키 가이샤 신규 지질트리펩티드성 히드로겔화제 및 히드로겔
CN107028792A (zh) * 2008-05-29 2017-08-11 唐纳德·欧文 皮肤美容组合物中的寡聚生物表面活性剂
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
WO2010082177A2 (en) 2009-01-16 2010-07-22 Sederma New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
CN102325543A (zh) * 2009-02-20 2012-01-18 帝斯曼知识产权资产管理有限公司 用于治疗红斑痤疮及其症状的包含n2-(1-氧代十六烷基)-赖氨酰-缬氨酰-赖氨酸的组合物
EP2408420A1 (en) * 2009-03-16 2012-01-25 DSM IP Assets B.V. Use of tripeptides
US8541361B2 (en) * 2009-04-22 2013-09-24 Dsm Ip Assets B.V. Composition
CN105664223B (zh) * 2009-10-26 2018-12-04 日产化学工业株式会社 化妆料、皮肤外用剂、以及医疗用仪器
US9566218B2 (en) * 2011-03-31 2017-02-14 Nissan Chemical Industries, Ltd. Production method of cosmetic, preparation method of gel for cosmetics, and method of reducing use amount of polymer thickener blended in cosmetic raw materials
RU2613121C2 (ru) 2011-05-10 2017-03-15 Мэри Кэй Инк. Косметические композиции
KR101167285B1 (ko) * 2011-11-18 2012-07-23 에이앤펩주식회사 피부 미백 활성을 갖는 나이아신-펩타이드 및 그의 용도
EP2793828B1 (en) * 2011-12-20 2016-08-24 Unilever PLC Moisturizing composition comprising an aminopeptide mixture
DE102012210379A1 (de) * 2012-06-20 2013-12-24 Beiersdorf Ag Kosmetische und dermatologische Zubereitung enthaltend eine oder mehrere Substanz(en), die das Gen / Protein für den Rezeptor Endo180 modulieren
US20140135269A1 (en) * 2012-10-01 2014-05-15 Peter Thomas Roth Labs, Llc Peptide And Protein-Based Formula For Improving The Appearance Of Skin
JP6115086B2 (ja) * 2012-11-13 2017-04-19 味の素株式会社 アミノ酸化合物の酢酸塩を含有する化粧料組成物
WO2014140890A2 (en) 2013-03-13 2014-09-18 Neocutis Sa Peptides for skin rejuvenation and methods of using the same
WO2015023926A1 (en) 2013-08-15 2015-02-19 Mary Kay Inc. Topical skin compositions for treating wrinkles
GB2549431A (en) 2014-12-29 2017-10-18 Kimberly Clark Co Multifunctional base emulsion
MX362727B (es) 2014-12-29 2019-02-05 Kimberly Clark Co Emulsiones cosméticas.
WO2016121822A1 (ja) * 2015-01-28 2016-08-04 国立大学法人九州大学 脂質ペプチド型化合物を含有する保湿基材
KR20170134653A (ko) * 2015-04-08 2017-12-06 디에스엠 아이피 어셋츠 비.브이. 배합물
CN107708660A (zh) * 2015-06-24 2018-02-16 日产化学工业株式会社 包含脂质肽型化合物的棒状基材
JP6996042B2 (ja) * 2016-09-15 2022-01-17 ディーエスエム アイピー アセッツ ビー．ブイ． 新規化合物
US12410143B2 (en) 2017-01-17 2025-09-09 Michael David FORREST Therapeutic inhibitors of the reverse mode of ATP synthase
BR112019028172A2 (pt) 2017-07-13 2020-10-06 Michael David Forrest moduladores terapêuticos do modo reverso da atp sintase
WO2019060357A1 (en) * 2017-09-21 2019-03-28 Muhammed Majeed PROCESS FOR THE PREPARATION OF TRIPEPTIDE CONTAINING OLEANOLIC ACID AND ASSOCIATED THERAPEUTIC APPLICATIONS
CN108047305B (zh) * 2017-12-08 2021-01-01 陕西慧康生物科技有限责任公司 一种十四烷基氨基丁酰缬氨酰胺基丁酸脲三氟乙酸盐的合成方法
CN107987123B (zh) * 2017-12-11 2021-01-01 陕西慧康生物科技有限责任公司 一种十四烷基氨基丁酰缬氨酰胺基丁酸脲三氟乙酸盐的液相合成方法
CN110423264B (zh) * 2019-08-26 2020-12-01 中国科学院长春应用化学研究所 一种基于活化酯高效制备棕榈酰三肽-5的方法
US20210106506A1 (en) * 2019-10-11 2021-04-15 Elc Management Llc Methods for cosmetic skin remodeling
MX2023007788A (es) 2021-01-24 2023-11-17 Michael David Forrest Inhibidores de la atp sintasa, usos cosmeticos y terapeuticos.
US12208150B2 (en) 2021-05-20 2025-01-28 Shielded, Beauty, LLC Antimicrobial skincare composition
IT202200016632A1 (it) * 2022-08-04 2024-02-04 Unifarco S P A Composizioni cosmetiche comprendenti un mix sinergico di attivi con efficacia antietà
AU2023400948A1 (en) * 2022-12-02 2025-06-19 Dsm Ip Assets B.V. Mandelic acid salt of palmitoyl lysylvalyl-lysine
WO2025252826A1 (en) 2024-06-04 2025-12-11 Dsm Ip Assets B.V. Composition comprising an acid addition salt of tetradecylaminocarbonyl-dab-val-dab-oh
WO2025252801A1 (en) * 2024-06-04 2025-12-11 Dsm Ip Assets B.V. Novel peptide compositions
WO2025252800A1 (en) * 2024-06-04 2025-12-11 Dsm Ip Assets B.V. Novel peptide compositions
CN118894902B (zh) * 2024-10-08 2024-12-24 云南苏理生物医药科技有限公司 肽衍生物及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5336477B1 (pt) * 1971-06-07 1978-10-03
DE2641500A1 (de) 1976-09-15 1978-03-16 Siemens Ag Halbleiteranordnung
US4389342A (en) * 1980-04-02 1983-06-21 Perignon Investments, Ltd. Synthetic hormone-like peptides and method for their synthesis
US4686282A (en) * 1983-08-12 1987-08-11 Immunetech, Inc. Immunotherapeutic polypeptide agents which block immune complex binding to immunoglobulin Fc receptors
IT1222437B (it) * 1987-08-04 1990-09-05 Ellem Ind Farmaceutica Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione
AU633005B2 (en) 1988-06-16 1993-01-21 Procyte Corporation Cosmetic and skin treatment compositions
US5028593A (en) * 1989-08-15 1991-07-02 Board Of Regents, The University Of Texas System Tuftsin analogs
US5593849A (en) * 1993-06-14 1997-01-14 Roy; Benjamin F. Method for detecting antibody against Staphylococcus aureus for replication protein B sequence 275-290 and Arg-Lys-Leu in human body fluids
FR2738746B1 (fr) * 1995-09-19 1997-11-14 Oreal Utilisation d'au moins un peptide dans une composition cosmetique ou pour la preparation d'un medicament
FR2740453B1 (fr) * 1995-10-27 1998-01-16 Bieurope Melanges peptidiques, leur preparation et compositions cosmetiques les contenant
CA2242911A1 (en) * 1996-01-16 1997-07-24 Kay C. Dee Peptides for altering osteoblast adhesion
WO1997037228A1 (en) * 1996-03-29 1997-10-09 The Trustees Of Boston University Methods for diagnosing and treating alzheimer's disease
US6333167B1 (en) * 2000-03-10 2001-12-25 American Home Products Corp. Methods and reagents for identifying inhibitors of proteolysis of membrane-associated proteins
FR2810323B1 (fr) 2000-06-16 2002-09-06 Shiseido Int France Utilisation cosmetique d'un lipopeptide
AU2001297591A1 (en) 2000-11-01 2002-09-19 Zengen, Inc. A sunburn treatment and sunburn prevention method
PL1625150T3 (pl) * 2003-05-08 2007-05-31 Dsm Ip Assets Bv Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry

Also Published As

Publication number Publication date
KR101116528B1 (ko) 2012-02-28
ES2280962T3 (es) 2007-09-16
US20070099842A1 (en) 2007-05-03
JP2007523841A (ja) 2007-08-23
US20110142895A1 (en) 2011-06-16
BRPI0410074B1 (pt) 2020-03-10
US8420778B2 (en) 2013-04-16
CA2525476A1 (en) 2004-11-18
WO2004099237A1 (de) 2004-11-18
EP1625150B1 (de) 2007-01-03
EP1625150A1 (de) 2006-02-15
US7863417B2 (en) 2011-01-04
RU2346949C2 (ru) 2009-02-20
EP1625150B9 (de) 2007-06-13
PL1625150T3 (pl) 2007-05-31
JP2011137021A (ja) 2011-07-14
JP4769709B2 (ja) 2011-09-07
KR20060009007A (ko) 2006-01-27
ATE350389T1 (de) 2007-01-15
CA2525476C (en) 2013-07-30
DE502004002556D1 (de) 2007-02-15
RU2005134130A (ru) 2006-06-27

Similar Documents

Publication Publication Date Title
BRPI0410074A (pt) compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele
CA2880275C (en) Pharmaceutical or cosmetic composition for treating alopecia
BR0308056A (pt) Composto, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto
ATE469161T1 (de) Pyrazolderivat, dieses enthaltende medizinische zusammensetzung, medizinische verwendung davon, und zwischenprodukt für dessen herstellung
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
MX2007003508A (es) Diaril ureas ciclicas adecuadas como inhibidores de tirosina cinasa.
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
BRPI0610087A2 (pt) composto para resfriamento
DE69128653D1 (de) Verwendung von Alphatocopherol phosphate oder eines Derivates davon zur Herstellung kosmetischer, dermatologischer oder pharmazeutischer Präparate mit anti-radikaler Aktivität und Zusammensetzungen
BRPI0414514A (pt) uso de um composto, composto, e, composições farmacêuticas
BR0315580A (pt) Derivados de metileno uréia
DE60224762D1 (de) Herstellung von Polysaccharidbetainatverbindungen, hergestellte Verbindungen, deren Verwendung und diese enthaltenden Zusammensetzungen
AR013079A1 (es) Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
CO5690599A2 (es) Derivados de 3-(4-aminofenil) tienopirimid-4-ona como antagonistas mch r1 para el tratamiento de obesidad, diabetes, depresion y ansiedad
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
ATE427944T1 (de) Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten
ECSP066947A (es) Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias
BRPI0411702A (pt) uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral
BRPI0507821A (pt) método de esticar o cabelo e uso de uma lactona
BR9909086A (pt) Derivados de piperidinila e n-amidinopiperidinila
AR001354A1 (es) Compuestos bi-aromaticos derivados de amida, composiciones farmacéuticas y cosméticas que los contien, y utilización de dichos compuestos y composición cosmética.
BR0313971A (pt) Composição de cuidado pessoal, método de cuidado com a pele ou cabelo, e, uso de um componente de álcool primário ramificado
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
AR029618A1 (es) Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos
ES2135695T3 (es) Derivados de aminoacidos y su uso como inhibidores de la fosfolipasa a2.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A NUIDADE.

B25A Requested transfer of rights approved

Owner name: DSM NUTRITIONAL PRODUCTS AG (CH)

Free format text: TRANSFERIDO POR FUSAO DE: PENTAPHARM AG

B25A Requested transfer of rights approved

Owner name: DSM IP ASSETS B.V. (NL)

Free format text: TRANSFERIDO DE: DSM NUTRITIONAL PRODUCTS AG

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART .8O COMBINADO COM ART. 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C07K 7/08 (2006.01), A61K 8/64 (2006.01), A61Q 19/

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2020, OBSERVADAS AS CONDICOES LEGAIS.